SLC12A5 and atypical Rett syndrome: In an animal model of Rett syndrome (MeCP2 mutant mouse), exhibiting reduced KCC2 activity, these molecules were able, by enhancing KCC2 expression levels, to restore a proper E/I balance and to ameliorate disease-associated respiratory and locomotion phenotypes.